Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Arthroplasty ; 30(10): 1842-6, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25971535

RESUMEN

Since the first use of ultra-high-molecular-weight polyethylene as a bearing material, research and development efforts have sought to improve wear resistance, increase longevity and lessen the potential for debris mediated adverse tissue responses. A series of second generation sequentially cross-linked and annealed tibial bearings were analysed after several bearings sent for routine retrieval analysis showed oxidative degradation including subsurface whitening, cracking and gross material loss. Evaluation incorporated visual and white banding assessment, mechanical testing and spectroscopy analysis. Whilst visual observation and white banding assessment confirmed oxidative changes, a decrease in mechanical properties and increasing ketone oxidation index as a function of time in vivo suggest time dependent oxidative degradation. Clinically relevant degradation of the sequentially cross-linked and annealed tibial bearings was observed.


Asunto(s)
Prótesis de Cadera , Polietilenos/química , Tibia/cirugía , Anciano , Reactivos de Enlaces Cruzados/química , Femenino , Humanos , Masculino , Ensayo de Materiales , Persona de Mediana Edad , Oxígeno/química , Polímeros/química , Espectroscopía Infrarroja por Transformada de Fourier , Estrés Mecánico
2.
J Hepatol ; 60(1): 135-42, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23968887

RESUMEN

BACKGROUND & AIMS: Extensive populations of liver immune cells detect and respond to homeostatic perturbation caused by damage, infection or malignancy. Dendritic cells (DCs) are central to these activities, governing the balance between tolerance and immunity. Most of our knowledge about human liver DCs is derived from studies on peritumoral tissue. Little is known about the phenotype and function of DCs, in particular the recently described CD141(+) subset, in healthy human liver and how this profile is altered in liver disease. METHODS: During liver transplantation, healthy donor and diseased explant livers were perfused and hepatic mononuclear cells isolated. Dendritic cell subset frequency and phenotype were characterised in liver perfusates by flow cytometry and the function of CD141(+) DCs was evaluated by mixed lymphocyte reactions (MLRs) and measuring cytokine secretion. RESULTS: Almost one third of liver CD11c(+) myeloid DCs (mDCs) expressed CD141 compared to <5% of circulating mDCs. Hepatic CD141(+) DCs demonstrated pro-inflammatory function in allogeneic MLRs, inducing T cell production of interferon gamma (IFN-γ) and interleukin (IL)-17. While CD123(+) plasmacytoid DCs (pDCs) and CD1c(+) mDCs were expanded in diseased liver perfusates, CD141(+) DCs were significantly depleted. Despite their depletion, CD141(+) DCs from explant livers produced markedly increased poly(I:C)-induced IFN lambda (IFN-λ) compared with donor DCs. CONCLUSIONS: Accumulation of CD141(+) DCs in healthy liver, which are significantly depleted in liver disease, suggests differential involvement of mDC subsets in liver immunity.


Asunto(s)
Antígenos de Superficie/análisis , Células Dendríticas/inmunología , Hígado/inmunología , Células Mieloides/inmunología , Adolescente , Adulto , Anciano , Femenino , Humanos , Lectinas Tipo C/análisis , Masculino , Glicoproteínas de Membrana/análisis , Persona de Mediana Edad , Receptores de Superficie Celular/análisis , Receptores Inmunológicos/análisis , Receptores Mitogénicos/análisis , Trombomodulina
3.
Plast Reconstr Surg ; 131(4): 480e-489e, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23249979

RESUMEN

BACKGROUND: Poly Implant Prothèse implants were recalled in Australia in April of 2010 following concerns of higher than expected rupture rates and the use of unauthorized industrial grade silicone as a filler material. Although subsequent investigations found that the gel filler material does not pose a threat to human health, the important question of what caused a relatively modern breast implant to have such a poor outcome compared with contemporary silicone breast implants is yet to be addressed. METHODS: From a cohort of 27 patients, 19 ruptured Poly Implant Prothèse breast implants were subjected to a range of mechanical tests and microscopic/macroscopic investigations to evaluate possible changes in properties as a result of implantation. New Poly Implant Prothèse implants were used as controls. RESULTS: All samples, explanted and controls, complied with the requirements for shell integrity as specified in the International Organization for Standardization 14607. Compression testing revealed rupture rates similar to those reported in the literature. Shell thickness was highly variable, with most shells having regions below the minimum thickness of 0.57 mm that was specified by the manufacturer. Potential regions of stress concentration were observed on the smooth inner surfaces and outer textured surfaces. CONCLUSIONS: The high incidence of Poly Implant Prothèse shell rupture is most likely a result of inadequate quality control, with contributory factors being shell thickness variation and manufacturing defects on both inner and outer surfaces of the shell. No evidence of shell degradation with implantation time was determined.


Asunto(s)
Implantes de Mama , Falla de Prótesis , Geles de Silicona , Remoción de Dispositivos , Femenino , Humanos , Ensayo de Materiales/métodos , Diseño de Prótesis
4.
PLoS One ; 6(11): e27866, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22114715

RESUMEN

The nucleoside analogue Ribavirin significantly increases patient response to IFN-α treatment of HCV, by directly inhibiting viral replication. Recent studies indicate that Ribavirin also regulates immunity and we propose that Ribavirin enhances specific interferon sensitive gene (ISG) expression by amplifying the IFN-α-JAK/STAT pathway. We found that IFN-α-induced STAT1 and STAT3 phosphorylation was increased in hepatocytes co-treated with Ribavirin and IFN-α, compared to IFN-α alone. Ribavirin specifically enhanced IFN-α induced mRNA and protein of the anti-viral mediator MxA, which co-localised with HCV core protein. These novel findings indicate for the first time that Ribavirin, in addition to its viral incorporation, also enhances IFN-α-JAK/STAT signalling, leading to a novel MxA-mediated immuno-modulatory mechanism that may enhance IFN-α anti-viral activity against HCV.


Asunto(s)
Antivirales/farmacología , Proteínas de Unión al GTP/metabolismo , Hepatitis C/tratamiento farmacológico , Hepatocitos/efectos de los fármacos , Hepatocitos/inmunología , Interferón-alfa/farmacología , Ribavirina/farmacología , Western Blotting , Células Cultivadas , Técnica del Anticuerpo Fluorescente , Proteínas de Unión al GTP/genética , Hepacivirus/efectos de los fármacos , Hepacivirus/inmunología , Hepacivirus/metabolismo , Hepatitis C/inmunología , Hepatitis C/virología , Hepatocitos/metabolismo , Humanos , Técnicas para Inmunoenzimas , Inmunoprecipitación , Proteínas de Resistencia a Mixovirus , Fosforilación/efectos de los fármacos , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Factor de Transcripción STAT1/genética , Factor de Transcripción STAT1/metabolismo , Factor de Transcripción STAT3/genética , Factor de Transcripción STAT3/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Proteínas del Núcleo Viral/genética , Proteínas del Núcleo Viral/metabolismo , Replicación Viral/efectos de los fármacos , Replicación Viral/inmunología
5.
Hepatology ; 53(6): 1846-53, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21452285

RESUMEN

UNLABELLED: T cell activation and the resultant production of interleukin (IL-2) is a central response of the adaptive immune system to pathogens, such as hepatitis C virus (HCV). HCV uses several mechanisms to evade both the innate and adaptive arms of the immune response. Here we demonstrate that liver biopsy specimens from individuals infected with HCV had significantly lower levels of IL-2 compared with those with other inflammatory liver diseases. Cell culture-grown HCV particles inhibited the production of IL-2 by normal peripheral blood mononuclear cells, as did serum from HCV-infected patients. This process was mediated by the interaction of HCV envelope protein E2 with tetraspanin CD81 coreceptor. HCV E2 attenuated IL-2 production at the level of secretion and not transcription by targeting the translocation of protein kinase C beta (PKCß), which is essential for IL-2 secretion, to lipid raft microdomains. The lipid raft disruptor methyl-ß-cyclodextrin reversed HCV E2-mediated inhibition of IL-2 secretion, but not in the presence of a PKCß-selective inhibitor. HCV E2 further inhibited the secretion of other cytokines, including interferon-γ. CONCLUSION: These data suggest that HCV E2-mediated disruption of the association of PKCß with the cellular secretory machinery represents a novel mechanism for HCV to evade the human immune response and to establish persistent infection.


Asunto(s)
Inmunidad Adaptativa/fisiología , Hepacivirus/fisiología , Evasión Inmune/fisiología , Inmunidad Innata/fisiología , Linfocitos T/metabolismo , Linfocitos T/virología , Antígenos CD/metabolismo , Biopsia , Línea Celular Tumoral , Células Cultivadas , Hepacivirus/patogenicidad , Humanos , Interleucina-2/metabolismo , Hígado/metabolismo , Hígado/patología , Hígado/virología , Microdominios de Membrana/fisiología , Proteína Quinasa C/metabolismo , Proteína Quinasa C beta , Linfocitos T/patología , Tetraspanina 28 , Proteínas del Envoltorio Viral/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA